Hinge Health (NYSE:HNGE) Earns Outperform Rating from Analysts at Royal Bank Of Canada

Royal Bank Of Canada initiated coverage on shares of Hinge Health (NYSE:HNGE) in a research report report published on Monday, Marketbeat reports. The brokerage issued an outperform rating and a $45.00 target price on the stock.

HNGE has been the topic of several other reports. Bank of America initiated coverage on shares of Hinge Health in a research report on Monday. They set a “buy” rating and a $42.00 target price on the stock. Canaccord Genuity Group started coverage on Hinge Health in a research report on Monday. They set a “buy” rating and a $52.00 price objective on the stock. Piper Sandler started coverage on Hinge Health in a research note on Monday. They issued an “overweight” rating and a $41.00 price objective for the company. Needham & Company LLC began coverage on Hinge Health in a research report on Monday. They set a “buy” rating and a $47.00 target price on the stock. Finally, Barclays initiated coverage on Hinge Health in a report on Monday. They set an “overweight” rating and a $43.00 price target on the stock. One equities research analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat.com, Hinge Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $46.00.

Hinge Health Stock Up 4.7%

Hinge Health stock opened at $39.79 on Monday. Hinge Health has a 52-week low of $33.42 and a 52-week high of $43.80.

About Hinge Health

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.